• Mon. Sep 26th, 2022

Natan Ponieman

  • Home
  • ‘A Hard Landing Scenario Is Inevitable’: Goldman Sachs Cuts S&P500 Targets As Investors Flock Into Cash – Bank of America (NYSE:BAC), Goldman Sachs Group (NYSE:GS)

‘A Hard Landing Scenario Is Inevitable’: Goldman Sachs Cuts S&P500 Targets As Investors Flock Into Cash – Bank of America (NYSE:BAC), Goldman Sachs Group (NYSE:GS)

Goldman Sachs GS is reducing its valuation projection for the S&P 500 as rising interest rates signal bad times for stock prices. Investors are reacting by shunning most asset classes and going…

Dow Jones Closes At 2022 Low As Investors Pull Back In ‘Uniquely Challenging Period’

Markets are reacting poorly to newly announced Fed measures this week to raise interest rates, fanning fears of a global recession that is becoming more palpable. The Dow Jones…

How Do You Build A Capital Stack Today’s Cannabis Market? Experts Weigh In

Entrepreneurs looking to build a company in the cannabis space often wonder what’s the best strategy for raising capital, and that includes setting up the right capital structure, also known…

WM Tech (NASDAQ:MAPS) – The 3 Main Issues Facing Cannabis Retailers Today And How To Solve Them, According To Weedmaps’ CEO

WM Technology Inc MAPS is best known for its online cannabis marketplace Weedmaps, but the company is also working hard on providing business solutions for brands and retailers across the cannabis market.…

Will The Fed Funds Rate Continue To Go Up? Fed Officials Weigh In On How To Reduce Inflation

The Federal Reserve is back on center stage as high inflation continues to drill holes in the pockets of Americans. What Happened On Wednesday, the Fed released its Beige Book for September, sharing…

Vanguard Forecasts The Next 10 Years: 65% Chance Of Recession, Bet On Value Stocks

The Vanguard Group is projecting an annualized return of between 4.1% and 6.1% for U.S. stocks over the next ten years, with value stocks beating those returns. The Valley Forge,…

‘Set Your Clock To It’: 2022’s Reliable Signal For When To Sell Stocks

“It’s getting to the point where you can set your clock to it,” read a Tuesday report by Bespoke Investment Group. What’s the market analysis firm referring to? Selling stocks…

Former Trump Allies Are Now Backing Liz Cheney As She Eyes 2024 Run, Including Billionaire Charles Koch

Rep. Liz Cheney is quickly rising as former President Donald Trump’s biggest critic within the Republican Party. According to a new CNBC report, the representative is amassing support from several of…

Manchin Rebuts Elon Musk, Michael Burry On The Biden IRS Funds: Here’s What The New Inflation Bill Actually Does

President Joe Biden signed into law a massive budget reconciliation bill this week known as the Inflation Reduction Act of 2022. The measure —which is expected by Democrats to reduce…

Saudi Prince Bought $500M Worth Of Russian Oil Stocks As Putin Declared War On Ukraine

Kingdom Holdings, a Saudi Arabian holding company founded by Saudi Prince Al Waleed bin Talal Al Saud, invested over $500 million in Russian oil companies at a pivotal moment, according to…

Why SoftBank’s Billionaire CEO Can’t Harness His Inner Warren Buffett And Buy The Market Dip

Japanese investment heavyweight SoftBank Group Corp reported a record $23-billion quarterly loss on Monday. The investment management group, which is heavily focused on tech, energy and communications, took a hard hit…

What Is The Stock Buyback Tax? What To Know About The Biden/Manchin/Sinema Compromise

With the support of Senator Kyrsten Sinema, Democrat lawmakers were able to secure sufficient votes for a new tax that will be introduced as part of the Inflation Reduction Act…

How China Could Respond If Nancy Pelosi Visits Taiwan — And The Stocks To Watch

The possibility of an unconfirmed visit to Taiwan by U.S. House Speaker Nancy Pelosi is causing tension to rise between the U.S. and China. If Pelosi were to consummate her…

Understanding The Psilocybin Supply Chain: Every Production Method Explained

Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As…